RB1 and nonpapillary renal cell carcinoma: Our characterisation of the Vhl/Trp53/Rb1 mutant mouse ccRCC model provides an experimental system that will allow the systematic dissection of the effects of individual and combined inhibition of these different checkpoint ligand/checkpoint receptor signalling systems on T cell activation in ccRCC.